Last updated on June 2018

PRASTERONE (DHEA) FOR THE TREATMENT OF HYPOACTIVE SEXUAL DESIRE DISORDER (HSDD) - (PLACEBO-CONTROLLED, DOUBLE-BLIND AND RANDOMIZED PHASE III STUDY OF 24-WEEK INTRAVAGINAL PRASTERONE) - PROTOCOL ERC-242


Find a site near you

Start Over

Pharmacology Research Institute, Los Alamitos

4281 Katella Avenue, Suite 115 Los Alamitos, CA USA
  Connect »

Recruitment Status: Open


Brief Description Eligibility Contact Research Team


Receive Emails About New Clinical Trials!

Sign up for our FREE service to receive email notifications when clinical trials are posted in the medical category of interest to you.